Community Nutrition Institute v. Young

Facts

The Food and Drug Administration established “action levels” for aflatoxins in corn, setting the permissible level at 20 parts per billion. These action levels informed food producers of allowable contamination levels, with producers who exceeded these levels subject to potential enforcement proceedings. The FDA characterized these action levels as non-binding statements of enforcement policy, but its regulations described them as “defining” acceptable levels and “prohibiting” certain substances. The FDA also granted exemptions allowing producers to blend contaminated corn with uncontaminated corn to bring the total contamination within acceptable levels. Community Nutrition Institute challenged these practices, arguing that the action levels were improperly promulgated without notice-and-comment procedures and that the blending practice violated the Food, Drug and Cosmetic Act by permitting adulterated food to enter commerce.

#Issue:
Do FDA’s action levels for aflatoxins in corn constitute legislative rules requiring notice-and-comment procedures under the Administrative Procedure Act, or are they interpretative rules or general statements of policy exempt from such requirements?

#Holding:
Yes, FDA’s action levels are legislative rules that require notice-and-comment procedures because the agency treated them as having present binding effect, despite characterizing them as policy statements.

#Concurring Opinions:
N/A

#Dissenting Opinions:
Judge Starr concurred with the court’s ruling on the blending issue but dissented on the action levels issue. He argued that the proper test should be whether the agency pronouncement has the force of law in subsequent proceedings. Since FDA would need to prove that corn is “adulterated” in enforcement proceedings rather than merely showing non-compliance with action levels, the action levels lack the force of law and should be considered policy statements.

#Reasoning and Analysis (Per Curiam):
The court examined whether FDA’s action levels fell within the exception to notice-and-comment requirements for “interpretative rules” or “general statements of policy.” Applying criteria from American Bus Association v. United States, the court considered whether the action levels had present binding effect and whether they left the agency free to exercise discretion. The court found that FDA’s own language in regulations and public statements treated action levels as presently binding norms that “defined” acceptable contamination levels. The court was particularly persuaded by FDA’s requirement that producers obtain “exceptions” to action levels, which implied that exceeding action levels was otherwise “unlawful.” While FDA would need to prove adulteration in court rather than merely showing violation of an action level, the court concluded that FDA had effectively bound itself by the action levels, making them substantive rules subject to notice-and-comment requirements. On the blending issue, the court held that while blended corn might technically be “adulterated” under the statute, FDA’s decision not to initiate enforcement action fell within its prosecutorial discretion and was not subject to judicial review.

#Policy:
The court’s decision reinforces the importance of procedural safeguards in administrative rulemaking while recognizing agency enforcement discretion. It establishes that agencies cannot avoid notice-and-comment requirements by labeling substantive rules as policy statements when they treat those statements as binding in practice.

#Where did the Court go from here?:
This decision established an important precedent for distinguishing between legislative rules and policy statements based on how agencies treat their own pronouncements in practice. The court emphasized that agencies cannot avoid notice-and-comment procedures by merely labeling substantive rules as policy statements. The case continues to be cited in administrative law for its analysis of when agency guidelines become binding rules requiring APA procedures.